Gegen Qinlian decoction alleviates experimental colitis via suppressing TLR4/NF-κB signaling and enhancing antioxidant effect

被引:123
|
作者
Li, Ruiyan [1 ]
Chen, Yingying [1 ,2 ]
Shi, Meijing [1 ]
Xu, Xinxin [1 ]
Zhao, Yaxing [1 ]
Wu, Xiaojun [2 ]
Zhang, Yubin [1 ]
机构
[1] China Pharmaceut Univ, Dept Biochem, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Gegen Qinlian decoction; UC; TLR4; NF-kappa B; Antioxidant effect; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; ALPHA PHOSPHORYLATION; TRANSCRIPTION FACTOR; ULCERATIVE-COLITIS; ACTIVATION; THIOREDOXIN; PEROXIDASE; INHIBITION;
D O I
10.1016/j.phymed.2016.06.010
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Gegen Qinlian decoction (GQ), a Chinese medicinal herb decoction, has been widely used as efficient medicine for the treatment of acute colitis in clinics, but underlying molecular mechanisms have not been fully clarified. Hypothesis/purpose: Inflammation and oxidative stress have been reported to constitute a crucial part in the pathogenesis of ulcerative colitis (UC). Hence, this study was designed to investigate the anti-inflammatory activity and antioxidative effect of GQ. Study design: Mice induced by 5% dextran sulfate sodium (DSS) and macrophage RAW264.7 cells stimulated by lipopolysaccharide (LPS) were used in this study. Methods: Ethanol extracts of GQ were orally administered for 1 week on the dosage of 0.3, 1.5, or 7.5 g/kg/day and berberine (BBR, 100 mg/kg/d) was selected as a positive group in the animal experiments. In vitro, GQ (25, 50, 100 mu g/ml) or BBR (20 mu M) co-cultured with RAW264.7 for 2 h prior to LPS stimulation. Results: The results showed that GQ oral administration alleviated the severity of colitis notably. It reduced toll-like receptor 4 (TLR4) expression and NF-kappa B activation in mucosa, which was accompanied with down regulation of several inflammatory cytokines in the colon, including tumor necrosis factor (TNF-alpha), interleukin (IL)-6, IL-1 beta and IL-4. Furthermore, GQ oral administration attenuated the oxidative stress in the colon of UC mice, evidenced by the decrease of myeloperoxidase (MPO) activity and malondialdehyde (MDA) level, and the elevation of glutathione (GSH) content. In parallel with the vivo experiment results, cell research indicated GQ dramatically reduced the production of TNF-alpha, IL-6, IL-1 beta and nitric oxide (NO), as well as that of reactive oxygen species (ROS) upon stimulation of LPS. Conclusion: Together, our present study indicates that inhibition of TLR4/NF-kappa B signaling and enhancement of antioxidant effect might be the potential mechanisms for the therapeutic effect of GQ against UC. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1012 / 1020
页数:9
相关论文
共 50 条
  • [21] Pinocembrin alleviates ulcerative colitis in mice via regulating gut microbiota, suppressing TLR4/MD2/NF-κB pathway and promoting intestinal barrier
    Yue, Bei
    Ren, Junyu
    Yu, Zhilun
    Luo, Xiaoping
    Ren, Yijing
    Zhang, Jing
    Mani, Sridhar
    Wang, Zhengtao
    Dou, Wei
    BIOSCIENCE REPORTS, 2020, 40
  • [22] Monotropein alleviates secondary liver injury in chronic colitis by regulating TLR4/NF-κB signaling and NLRP3 inflammasome
    Chen, Yonger
    Lu, Yingyu
    Pei, Chaoying
    Liang, Jian
    Ding, Ping
    Chen, Shuxian
    Hou, Shao-Zhen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883
  • [23] Nuciferine Inhibits Skin Cutaneous Melanoma Cell Growth by Suppressing TLR4/NF-κB Signaling
    Xu, Jingxing
    Ying, Anxin
    Shi, Tongxin
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (17) : 2099 - 2105
  • [24] Safinamide prevents lipopolysaccharide (LPS)-induced inflammation in macrophages by suppressing TLR4/NF-κB signaling
    Qian, LuLu
    Li, Jun-Zhao
    Sun, XueMei
    Chen, Jie-Bin
    Dai, Ying
    Huang, Qiu-Xiang
    Jin, Ying-Ji
    Duan, Qing-Ning
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [25] Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway
    Pan, Ni
    Lu, Liu-yi
    Li, Mei
    Wang, Guo-hao
    Sun, Fang-yun
    Sun, Hong-shuo
    Wen, Xue-jun
    Cheng, Jian-ding
    Chen, Jian-wen
    Pang, Ji-yan
    Liu, Jie
    Guan, Yong-yuan
    Zhao, Li-yan
    Chen, Wen-liang
    Wang, Guan-lei
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (09) : 1236 - 1247
  • [26] Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway
    Ni Pan
    Liu-yi Lu
    Mei Li
    Guo-hao Wang
    Fang-yun Sun
    Hong-shuo Sun
    Xue-jun Wen
    Jian-ding Cheng
    Jian-wen Chen
    Ji-yan Pang
    Jie Liu
    Yong-yuan Guan
    Li-yan Zhao
    Wen-liang Chen
    Guan-lei Wang
    Acta Pharmacologica Sinica, 2017, 38 : 1236 - 1247
  • [27] Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4/NF-κB signaling in monocytes
    Yang, Shuansuo
    Li, Ruogu
    Qu, Xinkai
    Tang, Lei
    Ge, Guanghao
    Fang, Weiyi
    Qiao, Zengyong
    Ma, Jiangwei
    Hou, Yuemei
    Liu, Huajin
    CELLULAR IMMUNOLOGY, 2013, 284 (1-2) : 182 - 186
  • [28] Activation of angiogenin expression in macrophages by lipopolysaccharide via the TLR4/NF-κB pathway in colitis
    Yao, Zhengrong
    Bai, Rongpan
    Liu, Wei
    Liu, Yaxing
    Zhou, Wei
    Xu, Zhengping
    Sheng, Jinghao
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (06): : 857 - 865
  • [29] Exercise intervention alleviates nerve injury by the suppression of inflammatory mediator expression via the TLR4/NF-κB signaling pathway
    Sun, Yan
    Liu, Jie Qiong
    Tian, Feng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (04) : 2922 - 2930
  • [30] Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway
    Xing, Yao
    Zhong, Liyuan
    Guo, Jun
    Bao, Cuifen
    Luo, Yumin
    Min, Lianqiu
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2024, 23 (08)